Biofrontera Inc.
Biofrontera Inc. (BFRI) Revenue
Annual & quarterly revenue history · segment & region breakdown
BFRI · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBiofrontera Inc. trailing twelve-month (TTM) revenue is $0.04B, an increase of 11.80% year-over-year from $0.04B in FY2025.
Revenue trend
2025 – 2019 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.04B | +$0.00B | +11.80% |
| 2024-12-31 | $0.04B | +$0.00B | +9.49% |
| 2023-12-31 | $0.03B | +$0.01B | +18.82% |
| 2022-12-31 | $0.03B | +$0.00B | +18.98% |
| 2021-12-31 | $0.02B | +$0.01B | +27.86% |
| 2020-12-31 | $0.02B | -$0.01B | -28.01% |
| 2019-12-31 | $0.03B | — | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Biofrontera Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Biofrontera Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Biofrontera Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BFRI revenue · 4 questionsBFRI's trailing twelve-month (TTM) revenue is $0.04B. That is an increase of 11.80% year-over-year from $0.04B in FY2025.
▸ Source: FMP · Biofrontera Inc. SEC filings · GAAP · Biofrontera Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026